$1.7 Million Awarded to Dr. Zahra Moussavi for Clinical Trial of rTMS for Treatment of Alzheimer’s disease

December 13, 2016

161213-ct14-moussavi-rtms-demo-umanitoba-editedDr. Zahra Moussavi, the Canada Research Chair in Biomedical Engineering in the Faculty of Engineering at the University of Manitoba, is receiving $1,737,960 from our Clinical Trials program for her project investigating the efficacy of high-frequency rTMS as a treatment for Alzheimer’s disease.

Based on previous results published in a pilot study funded by Riverview Health, the Institute is pleased to support this high risk, high reward research. This work will be performed at 3 sites – two in Canada and one in Australia.

Dr. Moussavi is currently recruiting participants for this study. Please contact us to learn more about joining.


Read the official press release from the University of Manitoba here.

Read more about Dr. Moussavi and her work with the Institute here.


Other media coverage:

CTV News Winnipeg

CBC Manitoba